GL1X · GenesisL1 explorer

Research workbench

H5 (VN1194) influenza virus haemagglutinin in complex with human receptor analogue 6'-sln

Analyse H5 (VN1194) influenza virus haemagglutinin in complex with human receptor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4BGX
Type
protein
Length
483 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemagglutinin
UniProt
Q6DQ34
Ligands
NAG, GAL, SIA
Pockets
4 · best druggability 0.59

Structure

x-ray diffraction · 2 distinct chains · 23% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHemagglutininprotein3219% helix, 40% strandQ6DQ34
BHemagglutininprotein16251% helix, 14% strandQ6DQ34

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains A, B
  • GAL · beta-D-galactopyranose · sugar · chains A
  • SIA · N-acetyl-alpha-neuraminic acid · sugar · chains A
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12970.590.7840empty
2560.390.8112empty
3540.350.7916empty
4600.290.7413empty

Interfaces

1 interface between chains.

  • A–B · 2461 Ų buried · 36 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 3 glycan (disulfide, N-glycosylation).

Compared structures

  • 4BGX · H5 (VN1194) Influenza Virus Haemagglutinin in Complex with Human Receptor Analogue 6'-SLN · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.